MedPath

Diphenoxylate Hydrochloride and Atropine Sulfate

Diphenoxylate Hydrochloride and Atropine Sulfate Oral Solution USP CV

Approved
Approval ID

b0c91667-ab6f-481d-a592-62da8a52abf7

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 20, 2017

Manufacturers
FDA

Atlantic Biologicals Corps

DUNS: 047437707

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Diphenoxylate Hydrochloride and Atropine Sulfate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code17856-3194
Application NumberANDA087708
Product Classification
M
Marketing Category
C73584
G
Generic Name
Diphenoxylate Hydrochloride and Atropine Sulfate
Product Specifications
Route of AdministrationORAL
Effective DateSeptember 8, 2016
FDA Product Classification

INGREDIENTS (11)

ALCOHOLInactive
Quantity: 0.75 mL in 5 mL
Code: 3K9958V90M
Classification: IACT
ATROPINE SULFATEActive
Quantity: 0.025 mg in 5 mL
Code: 03J5ZE7KA5
Classification: ACTIB
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSL
Classification: IACT
FD&C RED NO. 40Inactive
Code: WZB9127XOA
Classification: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
SORBITOLInactive
Code: 506T60A25R
Classification: IACT
MALTOLInactive
Code: 3A9RD92BS4
Classification: IACT
POTASSIUM SORBATEInactive
Code: 1VPU26JZZ4
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
DIPHENOXYLATE HYDROCHLORIDEActive
Quantity: 2.5 mg in 5 mL
Code: W24OD7YW48
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Diphenoxylate Hydrochloride and Atropine Sulfate - FDA Drug Approval Details